P-ISSN 2587-2400 | E-ISSN 2587-196X
Contact
EJMO Home
|
Toggle navigation
EJMO HOME
ABOUT JOURNAL
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
FOR REVIEWERS
EJMO ARCHIVE
CONTACT
EJMO Volume :
6
Issue :
4
Year :
2022
COVID-19 in EJMO
6/4
EJMO Current Issue
EJMO Archive
EJMO & Congress
Most Cited Articles
Ahead of Print
Most Accessed Articles
Copyright Transfer Form
ICMJE COI Form
EJMO Sponsors
Glead
Pfizer
Roche
Amgen
Astellas
Bristol-Myers Squibb
Arven
Johnson Johnson
Merck
Novartis
Omnigen
Mustafa Nevzat
TEVA
Trpharm
Ahead of Print
MiR-19a Mediates Epithelial Mesenchymal Transition of Breast Cancer by Inhibiting KRAS
Xianchou Xu, Peinan Wen, Yinghao Wang, Adheesh Bhandari, Riyuan Zhang, Shuqiang Shi, Ouchen Wang
doi:
10.14744/ejmo.2021.16863
Abstract
Therapeutic impact of Nano diosgenin on metabolic reprogramming in an animal model of mammary oncogenesis via modulating carbohydrate metabolizing enzymes
Manobharathi Vengaimaran, Kalaiyarasi Dhamodharan, Mirunalini Sankaran
doi:
10.14744/ejmo.2023.61011
Abstract
Abstracts of Oncology and immunotherapy association 2019 Congress
Abstracts of Oncology and immunotherapy association 2019 Congress
doi:
10.14744/ejmo.2019.2019
Abstract
|
Full Text PDF
|
PDF Download
A case of thyrotoxic hypochalemic periodic paralysis
Yilmaz Inanc, Deniz Tuncel, Mustafa Gokce, Hamza Sahin, Songül Bavli, Yusuf Inanc
doi:
10.14744/ejmo.2017.44154
Abstract
Dysplastic Adenoma in the Choledochal Cyst of an Adult: Biliary Papillomatosis
Ramazan Saygin Kerimoglu, Ebru Esen, Emet Ebru Nazik, Umut Ulusoy, Sumeyye Kozacioglu, Osman Dogru
doi:
10.14744/ejmo.2017.86580
Abstract
Follicular Thyroid Adenoma with Signet Ring Cell Morphology; A Rare Case Report
Mehmet Onur Ozturk, Mehmet Celik, Buket Yilmaz Bulbul, Tulin Deniz Yalta, Nuray Can, Semra Ayturk, Sibel Guldiken
doi:
10.14744/ejmo.2017.30602
Abstract
Abstracts of Oncology and immunotherapy association 2018 Congress
Abstracts Oncology and immunotherapy association
doi:
10.14744/ejmo.2018.2018
Abstract
|
Full Text PDF
|
PDF Download
ROS1 Rearrangement in Non Small Cell Lung Cancer: Where We are and Where We are going to.
Olga Nigro, Alessandro Tuzi, Graziella Pinotti
doi:
10.14744/ejmo.2020.42771
Abstract
Submit Manuscript
WEB OF SCİENCE click
Impact Factor:
Awaiting in 2023
Journal Citation Indicator :
0.39
Medicine, General & Internal:
Q2
135/329
SCOPUS click
CiteScoreTracker 2022:
0.9
CiteScore year 2021:
0.2
Google Scholar click
Number of Articles:
315
Citations:
2336
h-index:
15
i10-index:=
21
EJMO NLM ID:
101720527
Accept Ratio :
18.2 %
Final decision avg
34 day
Quick Search
In authors and institutes
In titles and abstracts
In keywords
In all
Copyright © 2023 Eurasian Journal of Medicine and Oncology, EJMO
EJMO & EJMO
